Product
CRS-HIPEC + LSTA1
1 clinical trial
4 indications
Indication
Colorectal CancerIndication
Ovarian CancerIndication
appendiceal cancerIndication
Peritoneal MetastasesClinical trial
A Phase I Trial of Intraperitoneal LSTA1 in Patients Undergoing Cytoreductive Surgery and HIPEC for Peritoneal Surface MalignancyStatus: Recruiting, Estimated PCD: 2028-12-01